216 related articles for article (PubMed ID: 32471100)
41. Structural characteristics and proximity comparison of China's urban innovation cooperation network.
Yuan Y; Han Z
PLoS One; 2021; 16(7):e0255443. PubMed ID: 34329363
[TBL] [Abstract][Full Text] [Related]
42. Social network analysis of a decade-long collaborative innovation network between hospitals and the biomedical industry in China.
Liu X; Chen H; Liu Y; Zou J; Tian J; Tsomo T; Li M; Yu W
Sci Rep; 2024 May; 14(1):11374. PubMed ID: 38762652
[TBL] [Abstract][Full Text] [Related]
43. Innovation in cardiovascular disease in Europe with focus on arrhythmias: current status, opportunities, roadblocks, and the role of multiple stakeholders.
Prinzen FW; Dagres N; Bollmann A; Arnar DO; Bove S; Camm J; Casadei B; Kirchhof P; Kuck KH; Lumens J; Michel MC; Schwartz PJ; Van Vleymen B; Vardas P; Hindricks G
Europace; 2018 May; 20(5):733-738. PubMed ID: 28605436
[TBL] [Abstract][Full Text] [Related]
44. Does the Low-Carbon City Pilot Policy Promote Green Technology Innovation? Based on Green Patent Data of Chinese A-Share Listed Companies.
Ma J; Hu Q; Shen W; Wei X
Int J Environ Res Public Health; 2021 Apr; 18(7):. PubMed ID: 33916230
[TBL] [Abstract][Full Text] [Related]
45. [The challenges of cardiac surgery: innovation, critical mind and ethics].
Musumeci F
G Ital Cardiol (Rome); 2019 Apr; 20(4):198-203. PubMed ID: 30920546
[No Abstract] [Full Text] [Related]
46. The impact of technology-environmental innovation on CO
Chen F; Zhao T; Liao Z
Environ Sci Pollut Res Int; 2020 Aug; 27(23):29485-29501. PubMed ID: 32445144
[TBL] [Abstract][Full Text] [Related]
47. Armed with innovation. Israel has become a prolific developer of new medical technologies and the nation's dominant defense industry is often the incubator.
Becker C
Mod Healthc; 2005 Apr; 35(14):26-9. PubMed ID: 15825959
[No Abstract] [Full Text] [Related]
48. Healthcare technology co-operatives: Innovative about innovation.
Heron NM; Tindale WB
J Med Eng Technol; 2014; 39(7):378-81. PubMed ID: 26453035
[TBL] [Abstract][Full Text] [Related]
49. Stock Market Liberalization and Corporate Green Innovation: Evidence from China.
Zhang Y; Zhang J; Cheng Z
Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33806099
[TBL] [Abstract][Full Text] [Related]
50. [Health new technology: Uber versus increase].
Thébaut JF
Presse Med; 2017 Jun; 46(6 Pt 1):561-564. PubMed ID: 28583746
[No Abstract] [Full Text] [Related]
51. The promise of biomedical innovation.
Weil AR
Health Aff (Millwood); 2015 Feb; 34(2):198. PubMed ID: 25646097
[No Abstract] [Full Text] [Related]
52. The impact of the opening of high-speed rail on corporate financing constraints.
Liao Y; Qiu X; Sun Q; Li P
PLoS One; 2022; 17(6):e0268994. PubMed ID: 35666715
[TBL] [Abstract][Full Text] [Related]
53. Biomedical innovation in the era of health care spending constraints.
Robinson JC
Health Aff (Millwood); 2015 Feb; 34(2):203-9. PubMed ID: 25646099
[TBL] [Abstract][Full Text] [Related]
54. [Opportunities and challenges for doctors in the transformation of medical science and technology achievements in China].
Li GX; Wang YN
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jun; 23(6):545-549. PubMed ID: 32521972
[TBL] [Abstract][Full Text] [Related]
55. Preparing for global health care innovation: virtual capstone design teams.
Goldberg J
IEEE Pulse; 2014; 5(1):70-2. PubMed ID: 25423679
[No Abstract] [Full Text] [Related]
56. Environmental Regulation, Two-Way Foreign Direct Investment, and Green Innovation Efficiency in China's Manufacturing Industry.
Feng Z; Zeng B; Ming Q
Int J Environ Res Public Health; 2018 Oct; 15(10):. PubMed ID: 30347639
[TBL] [Abstract][Full Text] [Related]
57. Knowledge search, knowledge integration and enterprise breakthrough innovation under the characteristics of innovation ecosystem network: The empirical evidence from enterprises in Beijing-Tianjin-Hebei region.
Zhang Y; Wang D; Xu L
PLoS One; 2021; 16(12):e0261558. PubMed ID: 34941906
[TBL] [Abstract][Full Text] [Related]
58. Effect of innovation capacity, production capacity and vertical specialization on innovation performance in China's electronic manufacturing: Analysis from the supply and demand sides.
Zhao T; Song Z; Li T
PLoS One; 2018; 13(7):e0200642. PubMed ID: 30011311
[TBL] [Abstract][Full Text] [Related]
59. Accelerating the innovation cycle: a Boston model seeks solutions for lagging ingenuity in health care.
Parrish JA; Schachter SC; Carleton PF; Dempsey M; Spilotis D; Collins J
IEEE Pulse; 2014; 5(1):46-54. PubMed ID: 25296373
[No Abstract] [Full Text] [Related]
60. [Innovation in pharmaceutical and health biotechnology industries: challenges for a virtuous agenda].
Vargas M; Gadelha CA; Costa LS; Maldonado J
Rev Saude Publica; 2012 Dec; 46 Suppl 1():37-40. PubMed ID: 23532311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
